NxStage Medical to Present at William Blair Growth Stock Conference

Friday, June 6, 2008 General News J E 4
LAWRENCE, Mass., June 5 NxStage Medical, Inc.(Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, todayannounced that Jeffrey H. Burbank, Chief Executive Officer, and Robert S.Brown, Chief Financial Officer, will be presenting at the William Blair 28thAnnual Growth Stock Conference on June 18, 2008 at the Four Seasons Hotel inChicago, Ill.

NxStage's investor presentation is scheduled for Wednesday, June 18th at3:10 p.m. CT. To listen to the audio webcast of the presentation during theevent, please visit: and click on 'InvestorInformation.' A replay will be available for 30 days immediately following thelive presentation.

About NxStage Medical

NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company,headquartered in Lawrence, Massachusetts, USA, that develops, manufactures andmarkets innovative products for the treatment of end-stage renal disease, orESRD, and acute kidney failure. For more information on NxStage and itsproducts, please visit the company's website at

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning ofthe Private Securities Litigation Reform Act of 1995. All statements containedin this release that are not clearly historical in nature are forward-looking,and the words "anticipate," "believe," "expect," "estimate," "plan," andsimilar expressions are generally intended to identify forward-lookingstatements. Examples of these forward-looking statements include statements asto Mr. Burbank's and Mr. Brown's plans to present at the William Blair GrowthStock Conference. NxStage specifically disclaims any obligation to updatethese forward-looking statements. These forward-looking statements should notbe relied upon as representing NxStage's expectations or beliefs as of anydate subsequent to the date of this press release.Contact: Kristen K. Sheppard, Esq. Investor Relations

SOURCE NxStage Medical, Inc.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Nuvelo Announces Publication of Preclinical Data F...
Healthy Interactions and Merck Announce Further Co...